Christie M Bartels1, Joanna C Wong2, Sophia L Johnson3, Carolyn T Thorpe4, Neal P Barney5, Nader Sheibani5, Maureen A Smith6. 1. Department of Medicine, Rheumatology Division, cb4@medicine.wisc.edu. 2. Department of Medicine, Rheumatology Division. 3. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI. 4. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA. 5. Department of Ophthalmology and Visual Sciences. 6. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, Department of Family Medicine and Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Abstract
OBJECTIVE: RA increases vascular disease and angiogenesis, yet a 1964 Lancet report paradoxically linked RA to lower diabetic retinopathy. Our objective was to examine RA as a risk factor for diabetic retinopathy compared with other vascular risk factors. METHODS: This cohort study compared the prevalence of diabetic retinopathy in diabetes patients with and without RA in a 5% Medicare sample. We analysed the impact of RA on the prevalence of diabetic retinopathy using multivariate logistic regression calculating adjusted rate ratios (ARRs) controlling for sociodemographics, co-morbidity and health utilization. Sensitivity analysis examined eye exam rates. RESULTS: Among 256 331 Medicare diabetes patients, 5572 (2%) had RA. Diabetic retinopathy was less prevalent in patients with RA compared with those without RA (13.7% vs 16.1%, P ≤ 0.01). Compared with patients without RA, the adjusted model demonstrated that patients with diabetes and RA were 28% less likely to have diabetic retinopathy and 4% more likely to receive an eye exam [ARR 0.72 (95% CI 0.67, 0.77), ARR 1.04 (95% CI 1.02, 1.06)]. CONCLUSION: Findings support the 1964 paradox observing decreased diabetic retinopathy in patients with RA. These findings pose new questions regarding whether RA physiology or treatments protect against diabetic retinopathy and how intraocular factors vary in contrast to adverse vascular changes elsewhere.
OBJECTIVE:RA increases vascular disease and angiogenesis, yet a 1964 Lancet report paradoxically linked RA to lower diabetic retinopathy. Our objective was to examine RA as a risk factor for diabetic retinopathy compared with other vascular risk factors. METHODS: This cohort study compared the prevalence of diabetic retinopathy in diabetespatients with and without RA in a 5% Medicare sample. We analysed the impact of RA on the prevalence of diabetic retinopathy using multivariate logistic regression calculating adjusted rate ratios (ARRs) controlling for sociodemographics, co-morbidity and health utilization. Sensitivity analysis examined eye exam rates. RESULTS: Among 256 331 Medicare diabetespatients, 5572 (2%) had RA. Diabetic retinopathy was less prevalent in patients with RA compared with those without RA (13.7% vs 16.1%, P ≤ 0.01). Compared with patients without RA, the adjusted model demonstrated that patients with diabetes and RA were 28% less likely to have diabetic retinopathy and 4% more likely to receive an eye exam [ARR 0.72 (95% CI 0.67, 0.77), ARR 1.04 (95% CI 1.02, 1.06)]. CONCLUSION: Findings support the 1964 paradox observing decreased diabetic retinopathy in patients with RA. These findings pose new questions regarding whether RA physiology or treatments protect against diabetic retinopathy and how intraocular factors vary in contrast to adverse vascular changes elsewhere.
Authors: David R Arday; Barbara B Fleming; Dana K Keller; Peter W Pendergrass; Robert J Vaughn; James M Turpin; David A Nicewander Journal: Diabetes Care Date: 2002-12 Impact factor: 19.112
Authors: Christie M Bartels; Jessica M Saucier; Carolyn T Thorpe; Amy J H Kind; Nancy Pandhi; Karen E Hansen; Maureen A Smith Journal: Arthritis Res Ther Date: 2012-07-18 Impact factor: 5.156
Authors: Antonia M Joussen; Sven Doehmen; Minh L Le; Kan Koizumi; Sven Radetzky; Tim U Krohne; Vassiliki Poulaki; Irina Semkova; Norbert Kociok Journal: Mol Vis Date: 2009-07-25 Impact factor: 2.367